Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.
Thank you. Please check your inbox to confirm.
Thursday's recommendation came after government advisers reviewed new safety data about rare but potentially life-threatening blood clots linked to J&J's shot.
A government advisory panel is meeting Thursday to determine if any restrictions are needed for the Johnson & Johnson COVID-19 vaccine because of rare but serious blood clots.
The Food and Drug Administration on Thursday cleared an extra dose for those ages 16 and 17, and the Centers for Disease Control and Prevention rapidly endorsed a booster for those ages.
About 900,000 kids aged 5 to 11 will have received their first dose of the COVID-19 vaccine in their first week of eligibility, the White House said, providing the first glimpse at the pace of the school-aged vaccination campaign.
The Food and Drug Administration already authorized the shots for children ages 5 to 11 — doses just a third of the amount given to teens and adults. But the Centers for Disease Control and Prevention recommends who should receive…
If the CDC’s director, Dr. Rochelle Walensky, signs off as expected, it will mark the first opportunity for Americans under 12 to get the powerful protection of any COVID-19 vaccine.
The Centers for Disease Control and Prevention advisory panel will have a discussion and vote Tuesday on the use of the Pfizer COVID-19 vaccine for children between the ages of five to 11.
U.S. health officials are changing their definition of lead poisoning in young children. The more stringent standard was announced Thursday.
A number of factors, including the vaccine you started with and when your last dose was, help determine when you qualify, according to recommendations issued Thursday by the Centers for Disease Control and Prevention.
Federal health officials say millions more Americans can get a COVID-19 booster and choose a different vaccine for that next shot.
Support Provided By: